# Multi-center Application of Bivalirudin in Left Atrial Appendage Occlusion

> **NCT04195997** · PHASE4 · UNKNOWN · sponsor: **Shanghai Zhongshan Hospital** · enrollment: 100 (estimated)

## Conditions studied

- Evaluate the Safety and Efficacy of Bivalirudin in Decreasing Bleeding Risk

## Interventions

- **DRUG:** Bivalirudin
- **DRUG:** Heparin

## Key facts

- **NCT ID:** NCT04195997
- **Lead sponsor:** Shanghai Zhongshan Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-02-01
- **Primary completion:** 2020-12-30
- **Final completion:** 2021-06-30
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2019-12-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04195997

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04195997, "Multi-center Application of Bivalirudin in Left Atrial Appendage Occlusion". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04195997. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*